Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study

BMC Public Health

Alexander Y Walley⁵  Al Ozonoff¹  Holly Hackman²  Amy Sorensen-Alawad⁵  Ziming Xuan³  Emily Quinn⁴  Maya Doe-Simkins⁵ 

[1] Harvard Medical School, Department of Pediatrics, 300 Longwood Avenue, Boston, MA 02115, USA;Massachusetts Department of Public Health, 250 Washington Street, Boston, MA 02108, USA;Department of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Avenue, Fourth Floor, Boston, MA 02118, USA;Data Coordinating Center, Boston University School of Public Health, 801 Massachusetts Avenue, Third Floor, Boston, MA 02118, USA;Clinical Addiction Research Education Unit, Section of General Internal Medicine, Boston University School of Medicine, 801 Massachusetts Avenue, Second Floor, Boston, MA 02118, USA

关键词: People who use drugs;    Rescue;    Bystander naloxone;    Opioids;    Overdose;   

Others  :  1131739
DOI  :  10.1186/1471-2458-14-297

 received in 2013-08-14, accepted in 2014-03-17,  发布年份 2014

【 摘 要 】

Background

One approach to preventing opioid overdose, a leading cause of premature, preventable mortality, is to provide overdose education and naloxone distribution (OEND). Two outstanding issues for OEND implementation include 1) the dissemination of OEND training from trained to untrained community members; and 2) the concern that OEND provides active substance users with a false sense of security resulting in increased opioid use.

Methods

To compare overdose rescue behaviors between trained and untrained rescuers among people reporting naloxone rescue kit use; and determine whether heroin use changed after OEND, we conducted a retrospective cohort study among substance users in the Massachusetts OEND program from 2006 to 2010. We used chi square and t-test statistics to compare the differences in overdose management characteristics among overdoses managed by trained versus untrained participants. We employed Wilcoxon signed rank test to compare median difference among two repeated measures of substance use among participants with drug use information collected more than once.

Results

Among 4,926 substance-using participants, 295 trained and 78 untrained participants reported one or more rescues, resulting in 599 rescue reports. We found no statistically significant differences in help-seeking (p = 0.41), rescue breathing (p = 0.54), staying with the victim (p = 0.84) or in the success of naloxone administration (p = 0.69) by trained versus untrained rescuers. We identified 325 OEND participants who had drug use information collected more than once. We found no significant overall change in the number of days using heroin in past 30 days (decreased 38%, increased 35%, did not change 27%, p = 0.52).

Conclusion

Among 4926 substance users who participated in OEND, 373(7.6%) reported administering naloxone during an overdose rescue. We found few differences in behavior between trained and untrained overdose rescuers. Prospective studies will be needed to determine the optimal level of training and whether naloxone rescue kits can meet an over-the-counter standard. With no clear evidence of increased heroin use, this concern should not impede expansion of OEND programs or policies that support them.

【 授权许可】

   
2014 Doe-Simkins et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Centers for Disease Control and Prevention (CDC): Vital signs: overdoses of prescription opioid pain relievers and other drugs among women — United States, 1999–2010. MMWR Morb Mortal Wkly Rep 2013, 62(26):537-542.
• [2]Centers for Disease Control and Prevention (CDC): National vital statistics reports: deaths: final data for 2009. Natl Vital Stat Rep 2011, 60(3):81-82.
• [3]Massachusetts Department of Public Health: 2008 death report. http://www.mass.gov/eohhs/docs/dph/research-epi/death-report-08.pdf webcite
• [4]Milloy MJ, Wood E, Reading C, Kane D, Montaner J, Kerr T: Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis. Addiction 2010, 105(11):1962-1970.
• [5]Leece PN, Hopkins S, Marshall C, Orkin A, Gassanov MA, Shahin RM: Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Can J Public Health 2013, 104(3):e200-e204.
• [6]European Monitoring Centre for Drugs and Drug Addiction: Annual report 2011: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union 2011, 87-91.
• [7]Coffin P: Overdose: A Major Cause of Preventable Death in Central and Eastern Europe in Central Asia: recommendations and overview of the situation in Latvia, Kyrgyzstan, Romania, Russia and Tajikistan. Eurasian Harm Reduction Network (EHRN) 2008, 1-78.
• [8]Quan VM, Minh NL, Ha TV, Ngoc NP, Vu PT, Celentano DD, Mo TT, Go VF: Mortality and HIV transmission among male Vietnamese injection drug users. Addiction 2011, 106(3):583-589.
• [9]Stafford J, Burns L: Australian Drug Trends 2010. Findings from the Illicit Drug Reporting System (IDRS). Aust Drug Trend Ser 2011, 55.
• [10]Burris S, Norland J, Edlin B: Legal aspects of providing naloxone to heroin users in the United States. Int J Drug Policy 2001, 12(3):237-248.
• [11]Wermeling DP: A response to the opioid overdose epidemic: naloxone nasal spray. Drug Deliv Transl Res 2013, 3(1):63-74.
• [12]Wermeling DP: Opioid harm reduction strategies: focus on expanded access to intranasal naloxone. Pharmacotherapy 2010, 30(7):627-631.
• [13]Albert S, Brason FW II, Sanford CK, Dasgupta N, Graham J, Lovette B: Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med 2011, 12(Suppl 2):S77-S85.
• [14]Zaller ND, Yokell MA, Green TC, Gaggin J, Case P: The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse 2013, 48(8):590-599.
• [15]Baca CT, Grant KJ: Take-home naloxone to reduce heroin death. Addiction 2005, 100(12):1823-1831.
• [16]Bennett AS, Bell A, Tomedi L, Hulsey EG, Kral AH: Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health 2011, 88(6):1020-1030.
• [17]Dettmer K, Saunders B, Strang J: Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ 2001, 322(7291):895-896.
• [18]Doe-Simkins M, Walley AY, Epstein A, Moyer P: Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009, 99(5):788-791.
• [19]Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, Bamberger JD: Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010, 87(6):931-941.
• [20]Green TC, Heimer R, Grau LE: Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008, 103(6):979-989.
• [21]Lankenau SE, Wagner KD, Silva K, Kecojevic A, Iverson E, McNeely M, Kral AH: Injection drug users trained by overdose prevention programs: Responses to witnessed overdoses. J Community Health 2013, 38(1):133-141.
• [22]Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S: Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006, 25(3):89-96.
• [23]Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, Galea S: Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008, 43(7):858-870.
• [24]Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, Downing M, Edlin BR: Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 2005, 82(2):303-311.
• [25]Sporer KA, Kral AH: Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007, 49(2):172-177.
• [26]Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, Gonzalez M, Unger JB: Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010, 21(3):186-193.
• [27]Centers for Disease Control and Prevention (CDC): Community-based opioid overdose prevention programs providing naloxone - United States, 2010. MMWR Morb Mortal Wkly Rep 2012, 61:101-105.
• [28]Opioid overdose: preventing and reducing opioid overdose mortality http://www.unodc.org/docs/treatment/overdose.pdf webcite
• [29]Comprehensive HIV prevention for people who inject drugs, revised guidance http://www.pepfar.gov/documents/organization/144970.pdf webcite
• [30]Preventing overdose through education and naloxone distribution http://www.apha.org/advocacy/policy/policysearch/default.htm?id=1443 webcite
• [31]Compton WM, Volkow ND, Throckmorton DC, Lurie P: Expanded access to opioid overdose intervention: research, practice, and policy needs. Ann Intern Med 2013, 158(1):65-66.
• [32]Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A: Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013, 346:f174.
• [33]Coffin PO, Sullivan SD: Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med 2013, 158(1):1-9.
• [34]McAuley A, Lindsay G, Woods M, Louttit D: Responsible management and use of a personal take-home naloxone supply: a pilot project. Drugs Educ Prev Policy 2010, 17(4):388-199.
• [35]Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, Offor E, Semmler C: Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008, 103(10):1648-1657.
• [36]Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA: Evaluation of the staying alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009, 20(2):131-136.
• [37]Kim D, Irwin KS, Khoshnood K: Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health 2009, 99(3):402-407.
• [38]Bazazi AR, Zaller ND, Fu JJ, Rich JD: Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved 2010, 21(4):1108-1113.
• [39]Osterwalder JJ: Naloxone–for intoxications with intravenous heroin and heroin mixtures–harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996, 34(4):409-416.
• [40]Ashworth AJ, Kidd A: Take home naloxone for opiate addicts. Apparent advantages may be balanced by hidden harms. BMJ 2001, 323(7318):935.
• [41]Hurley D: Emergency antidote, direct to addicts. http://www.nytimes.com/2007/12/11/science/11hero.html?pagewanted=print webcite
• [42]Knox R: Overdose rescue kits save lives. http://www.npr.org/templates/story/story.php?storyId=17578955 webcite
• [43]Mountain D: Take home naloxone for opiate addicts. Big conclusions are drawn from little evidence. BMJ 2001, 323(7318):934. author reply 935
• [44]Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, Ciccarone D, Edlin BR: Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health 2003, 80(2):291-301.
• [45]Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM: Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav 2006, 31(5):907-912.
• [46]Overdose prevention pilot core competencies http://www.mass.gov/eohhs/docs/dph/substance-abuse/core-competencies-for-naloxone-pilot-participants.pdf webcite
• [47]Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A: Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat 2013, 44(2):241-247.
• [48]Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P: “The life they save may be mine”: diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy 2008. [Epub ahead of print]
• [49]Jones JD, Roux P, Stancliff S, Matthews W, Comer SD: Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users. Int J Drug Policy 2014, 25(1):166-170.
• [50]Gaston RL, Best D, Manning V, Day E: Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J 2009, 6:26-7517-6-26.
• [51]Role of naloxone in opioid overdose fatality prevention; request for comments; public workshop http://www.fda.gov/drugs/newsEvents/ucm277119.htm webcite
• [52]Calcaterra S, Glanz J, Binswanger IA: National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend 2013, 131(3):263-270.
• [53]Substance Abuse and Mental Health Services Administration: Drug Abuse Warning Network, 2009: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 11-4659, DAWN Series D-35. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
• [54]Darke S, Williamson A, Ross J, Teesson M, Lynskey M: Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004, 74(1):77-83.
• [55]Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M: Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003, 326(7396):959-960.
• [56]Cicero TJ, Ellis MS, Surratt HL: Effect of abuse-deterrent formulation of OxyContin. N Engl J Med 2012, 367(2):187-189.